Skip to main content

Table 3 Comparative analysis according to the intraoperative assessment results, n = 222

From: Diagnostic performance of intraoperative assessment in grade 2 endometrioid endometrial carcinoma

  IOA negative IOA positive P
142 (64%) 80 (36%)
Agea 53.7 ± 11.4 56 ± 12.2 0.166
Menopause 108 (76%) 62 (77.5%) 0.807
Weight, kgb 74.5 (65.5-85.5) 68.5 (60-80.5) 0.079
BMIa 32.6 ± 6.7 31.1 ± 7.1 0.131
Surgical stage
 I 120 (84.5%) 42 (52.5%) < 0.001
 II 12 (8.5%) 13 (16.3%)  
 III 8 (5.6%) 22 (27.5%)  
 IV 2 (1.4%) 3 (3.8%)  
Lymph node metastasis 7 (4.9%) 16 (20%) < 0.001
Lymphadenectomy 18 (12.7%) 69 (86.3%) < 0.001
Bleeding, mlb 150 (80-300) 375 (200-550) < 0.001
Transfusion 0 (0%) 8 (10%) < 0.001
Reintervention 2 (1.4%) 3 (3.8%) 0.277
ICU 2 (1.4%) 5 (6.3%) 0.07
Adjuvant therapy 44 (31%) 62 (77.5%) < 0.001
 Radiotherapy 41 (28.9%) 58 (72.5%) 0.94
 Chemotherapy 8 (5.6%) 22 (27.5%) 0.049
Recurrence of disease 7 (4.9%) 8 (10%) 0.156
  1. FSB frozen section biopsy, BMI body mass index, ICU intensive care unit, IOA intraoperative assessment
  2. aMean ± standard deviation
  3. bMedian (interquartile range)